Selective contracting is a popular tool for reducing health care costs, but these savings must be weighed against consumer surplus losses from restricted access. In public and private prescription drug plans, issuers utilize preferred pharmacy networks to reduce drug prices. We show that, in the Medicare Part D program, drug plans with restrictive preferred pharmacy networks pay lower retail drug prices; however, enrollee insensitivity to preferred pharmacy copay discounts leads to higher prices. We then estimate plan and pharmacy demand models to quantify the costs and benefits of selective contracting with heterogeneous enrollee sensitivity to benefit design.
Starc, Amanda, and Ashley Swanson. "Preferred Pharmacy Networks and Drug Costs." Columbia Business School, August 19, 2018.
Each author name for a Columbia Business School faculty member is linked to a faculty research page, which lists additional publications by that faculty member.
Each topic is linked to an index of publications on that topic.